Side effects of antituberculosis therapy [6] (multiple letters)

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 10, 2004, Pages 1168-1169

  Leung, Chi Chiu ^a   Chan, Chi Kuen ^a   Yew, Wing Wai ^b   Yee, Daphne P ^c   Menzies, Dick ^c  

^a Department of Health ^*  (Hong Kong)

^b GRANTHAM HOSPITAL   (Hong Kong)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PLACEBO; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANALYTIC METHOD; CALCULATION; CLINICAL TRIAL; DRUG INDUCED DISEASE; DRUG SAFETY; GROUPS BY AGE; HUMAN; INCIDENCE; LETTER; LIVER TOXICITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; TOXIC HEPATITIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAXIMUM TOLERATED DOSE; PROPORTIONAL HAZARDS MODELS; PYRAZINAMIDE; RISK ASSESSMENT; TUBERCULOSIS, PULMONARY;

EID: 2442424430     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)